SEC Form 4 · accession 0001209191-17-052894
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dirk G. Brockstedt
Officer — EVP of Research and Dev.
Period of report
Sep 12, 2017
Accepted (ET)
Sep 14, 2017 · 9:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 12, 2017 | A | 27,975 | $0.00 | A | 77,275 | D | |
| Common Stock | Sep 13, 2017 | S | 3,557 | $10.9858 | D | 73,718 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2017.
- F2The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.